United States Neurosurgical Products Market Outlook to 2023

  • ID: 4308002
  • Report
  • Region: United States
  • 81 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • KARL STORZ GmbH & Co KG
  • Medtronic Plc
  • Stryker Corporation
  • MORE
United States Neurosurgical Products Market Outlook to 2023

Summary

The new report, "United States Neurosurgical Products Market Outlook to 2023", provides key market data on the United States Neurosurgical Products market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Neuroendoscopes and Neurosurgical Drills.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neurosurgical Products market segments - Neuroendoscopes and Neurosurgical Drills.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Neurosurgical Products market.
- Key players covered include B. Braun Melsungen AG, Medtronic plc, KARL STORZ GmbH & Co KG and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • KARL STORZ GmbH & Co KG
  • Medtronic Plc
  • Stryker Corporation
  • MORE
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurosurgical Products Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurosurgical Products Market, United States
3.1 Neurosurgical Products Market, United States, Revenue ($m), 2009-2016
3.2 Neurosurgical Products Market, United States, Revenue ($m), 2016-2023
3.3 Neurosurgical Products Market, United States, Volume (Units), 2009-2016
3.4 Neurosurgical Products Market, United States, Volume (Units), 2016-2023
3.5 Neurosurgical Products Market, United States, Average Price ($), 2009-2023
3.6 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Neurosurgical Products Market
4.1 B. Braun Melsungen AG
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 KARL STORZ GmbH & Co KG
4.3.1 Company Overview
4.4 Stryker Corporation
4.4.1 Company Overview
5 Neurosurgical Products Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Boston Scientific Acquires Cosman Medical
6.2 Asset Transactions
6.2.1 Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion
6.3 Equity Offerings
6.3.1 Transgenomic to Raise up to USD7 Million in Private Placement of Shares
6.3.2 MRI Interventions to Raise USD4.3 Million in Private Placement of Units
6.4 Venture Financing
6.4.1 Checkpoint Surgical Raises USD0.5 Million in Venture Financing
6.4.2 Monteris Medical Raises USD6.8 Million in Venture Financing
6.4.3 Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions’ Board of Directors
7.1.2 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing
7.1.3 Feb 20, 2017: ACERA Selected as One of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer
7.1.4 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer
7.1.5 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO
7.1.6 Dec 05, 2016: Integra LifeSciences announces management changes
7.1.7 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments
7.1.8 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors
7.1.9 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire
7.1.10 Jul 21, 2016: BrainScope Appoints Medical Device Industry Veteran Andrew Holman as Chief Commercial Officer
7.1.11 Jul 19, 2016: Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
7.1.12 Jun 30, 2016: Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer
7.2 Financial Announcements
7.2.1 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017
7.2.2 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results
7.2.3 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results
7.2.4 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
7.2.5 Apr 25, 2017: Stryker reports first quarter 2017 results
7.2.6 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years
7.2.7 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter
7.2.8 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results
7.2.9 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth
7.2.10 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
7.2.11 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017
7.2.12 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
7.2.13 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues
7.2.14 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
7.2.15 Nov 04, 2016: MRI Interventions Announces 2016 Third Quarter and Nine Month Results
7.2.16 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017
7.2.17 Oct 27, 2016: Stryker reports third quarter 2016 results
7.2.18 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results
7.2.19 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results
7.2.20 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
7.2.21 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results
7.2.22 Aug 12, 2016: Transgenomic Reports Second Quarter 2016 Financial Results
7.2.23 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook
7.2.24 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results
7.2.25 Jul 27, 2016: RTI Surgical Announces 2016 Second Quarter Results
7.2.26 Jul 21, 2016: Stryker reports second quarter 2016 results
7.2.27 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
7.2.28 May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results
7.3 Legal And Regulatory
7.3.1 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia
7.3.2 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ
7.3.3 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS' petition and institutes IPR against NPE patent holder AMI
7.3.4 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
7.4 Other Significant Developments
7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
7.4.2 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board
7.4.3 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
7.5 Product News
7.5.1 Feb 23, 2017: Avella Specialty Pharmacy recall sterile products produced at Advanced Pharma Houston Location from September 1, 2016 through February 16, 2017 Due to Potential Inaccuracy of Latex Free Label Reference
7.6 Strategy And Business Planning
7.6.1 Sep 20, 2016: Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer

1.1 List of Tables
Table 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Neurosurgical Products Market, United States, Volume (Units), Historic, 2009-2016
Table 4: Neurosurgical Products Market, United States, Volume (Units), Forecast, 2016-2023
Table 5: Neurosurgical Products Market, United States, Average Price ($), Historic, 2009-2016
Table 6: Neurosurgical Products Market, United States, Average Price ($), Forecast, 2016-2023
Table 7: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurosurgical Products Market Pipeline Products
Table 10: Boston Scientific Acquires Cosman Medical
Table 11: Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion
Table 12: Transgenomic to Raise up to USD7 Million in Private Placement of Shares
Table 13: MRI Interventions to Raise USD4.3 Million in Private Placement of Units
Table 14: Checkpoint Surgical Raises USD0.5 Million in Venture Financing
Table 15: Monteris Medical Raises USD6.8 Million in Venture Financing
Table 16: Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing

1.2 List of Figures
Figure 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Neurosurgical Products Market, United States, Volume (Units), Historic, 2009-2016
Figure 4: Neurosurgical Products Market, United States, Volume (Units), Forecast, 2016-2023
Figure 5: Neurosurgical Products Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Medtronic Plc
  • KARL STORZ GmbH & Co KG
  • Stryker Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll